サマリー

プロトンポンプ阻害薬（PPI）の世界市場 2024-2028
プロトンポンプ阻害薬（PPI）市場は、2023年から2028年にかけて8億789万米ドルの成長が予測され、予測期間中のCAGRは4.86%で加速すると予測されます。当レポートでは、プロトンポンプ阻害薬（PPI）市場の全体的な分析、市場規模や予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、薬剤の再製剤化、処方率の伸び、胃食道逆流症の旺盛な流行によって牽引されています。
Technavio社のプロトンポンプ阻害薬（PPI）市場は以下のように区分されています：
製品別
- OTC PPI
- 処方薬PPI
投与経路別
- 経口剤
- 注射剤
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間におけるプロトンポンプ阻害薬（PPI）市場の成長を促進する主な理由の一つとして、高齢者人口の増加を挙げています。また、肥満の有病率の上昇と個別化されたPPI療法は、市場の大きな需要につながります。
当レポートでは、プロトンポンプ阻害薬（PPI）市場について、以下の分野をカバーしています：
- プロトンポンプ阻害薬（PPI）市場のサイジング
- プロトンポンプ阻害薬（PPI）市場予測
- プロトンポンプ阻害薬（PPI）市場の産業分析
バイエル社、シプラ社、ドクター・レッディーズ・ラボラトリーズ社、エーザイ社、イーライリリー社、グレンマーク社、ジョンソン・エンド・ジョンソン社、ペリゴ社、ファイザー社、オーロビンド・ファーマ社、バイエル社、シプラ社、ドクター・レッディーズ・ラボラトリーズ社、エーザイ社PLC、ファイザー社、レッドヒル・バイオファーマ社、サノフィ社、サン・ファーマシューティカル・インダストリーズ社、武田薬品工業社、テバ・ファーマシューティカル・インダストリーズ社Ltd.、テバ・ファーマシューティカル・インダストリーズLtd.、ザ・プロクター・アンド・ギャンブルCo.、ザイダス・ライフサイエンスLtd.また、プロトンポンプ阻害剤（PPI）市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/proton-pump-inhibitors-ppis-service-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global proton pump inhibitors (PPIs) market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global proton pump inhibitors (ppis) market 2018 - 2022 ($ million)
o 4.2 Product Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
o 4.3 Route of Administration Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 OTC PPIs - Market size and forecast 2023-2028
o Exhibit 34: Chart on OTC PPIs - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on OTC PPIs - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on OTC PPIs - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on OTC PPIs - Year-over-year growth 2023-2028 (%)
o 6.4 Prescription PPIs - Market size and forecast 2023-2028
o Exhibit 38: Chart on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Prescription PPIs - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Prescription PPIs - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
o Exhibit 43: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 44: Chart on Route of Administration - Market share 2023-2028 (%)
o Exhibit 45: Data Table on Route of Administration - Market share 2023-2028 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 46: Chart on Comparison by Route of Administration
o Exhibit 47: Data Table on Comparison by Route of Administration
o 7.3 Oral - Market size and forecast 2023-2028
o Exhibit 48: Chart on Oral - Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on Oral - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Oral - Year-over-year growth 2023-2028 (%)
o 7.4 Injectable - Market size and forecast 2023-2028
o Exhibit 52: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Injectable - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Route of Administration
o Exhibit 56: Market opportunity by Route of Administration ($ million)
o Exhibit 57: Data Table on Market opportunity by Route of Administration ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 Canada - Market size and forecast 2023-2028
o Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.11 UK - Market size and forecast 2023-2028
o Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 107: Amgen Inc. - Overview
o Exhibit 108: Amgen Inc. - Product / Service
o Exhibit 109: Amgen Inc. - Key offerings
o 12.4 AstraZeneca Plc
o Exhibit 110: AstraZeneca Plc - Overview
o Exhibit 111: AstraZeneca Plc - Product / Service
o Exhibit 112: AstraZeneca Plc - Key news
o Exhibit 113: AstraZeneca Plc - Key offerings
o 12.5 Aurobindo Pharma Ltd.
o Exhibit 114: Aurobindo Pharma Ltd. - Overview
o Exhibit 115: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 116: Aurobindo Pharma Ltd. - Key offerings
o 12.6 Bausch Health Companies Inc.
o Exhibit 117: Bausch Health Companies Inc. - Overview
o Exhibit 118: Bausch Health Companies Inc. - Business segments
o Exhibit 119: Bausch Health Companies Inc. - Key news
o Exhibit 120: Bausch Health Companies Inc. - Key offerings
o Exhibit 121: Bausch Health Companies Inc. - Segment focus
o 12.7 Bayer AG
o Exhibit 122: Bayer AG - Overview
o Exhibit 123: Bayer AG - Business segments
o Exhibit 124: Bayer AG - Key news
o Exhibit 125: Bayer AG - Key offerings
o Exhibit 126: Bayer AG - Segment focus
o 12.8 Dr Reddys Laboratories Ltd.
o Exhibit 127: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 128: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 129: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 130: Dr Reddys Laboratories Ltd. - Segment focus
o 12.9 Eisai Co. Ltd.
o Exhibit 131: Eisai Co. Ltd. - Overview
o Exhibit 132: Eisai Co. Ltd. - Business segments
o Exhibit 133: Eisai Co. Ltd. - Key offerings
o Exhibit 134: Eisai Co. Ltd. - Segment focus
o 12.10 Eli Lilly and Co.
o Exhibit 135: Eli Lilly and Co. - Overview
o Exhibit 136: Eli Lilly and Co. - Product / Service
o Exhibit 137: Eli Lilly and Co. - Key news
o Exhibit 138: Eli Lilly and Co. - Key offerings
o 12.11 Glenmark Pharmaceuticals Ltd.
o Exhibit 139: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 140: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 141: Glenmark Pharmaceuticals Ltd. - Key offerings
o 12.12 Pfizer Inc.
o Exhibit 142: Pfizer Inc. - Overview
o Exhibit 143: Pfizer Inc. - Product / Service
o Exhibit 144: Pfizer Inc. - Key news
o Exhibit 145: Pfizer Inc. - Key offerings
o 12.13 Sun Pharmaceutical Industries Ltd.
o Exhibit 146: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 147: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 148: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.14 Takeda Pharmaceutical Co. Ltd.
o Exhibit 149: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 150: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 151: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 152: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.15 Teva Pharmaceutical Industries Ltd.
o Exhibit 153: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 154: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 155: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 156: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 157: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.16 The Procter and Gamble Co.
o Exhibit 158: The Procter and Gamble Co. - Overview
o Exhibit 159: The Procter and Gamble Co. - Business segments
o Exhibit 160: The Procter and Gamble Co. - Key news
o Exhibit 161: The Procter and Gamble Co. - Key offerings
o Exhibit 162: The Procter and Gamble Co. - Segment focus
o 12.17 Zydus Lifesciences Ltd.
o Exhibit 163: Zydus Lifesciences Ltd. - Overview
o Exhibit 164: Zydus Lifesciences Ltd. - Business segments
o Exhibit 165: Zydus Lifesciences Ltd. - Key offerings
o Exhibit 166: Zydus Lifesciences Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 167: Inclusions checklist
o Exhibit 168: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 169: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 170: Research methodology
o Exhibit 171: Validation techniques employed for market sizing
o Exhibit 172: Information sources
o 13.5 List of abbreviations
o Exhibit 173: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global proton pump inhibitors (ppis) market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on OTC PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on OTC PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on OTC PPIs - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on OTC PPIs - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Prescription PPIs - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Prescription PPIs - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits45: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Route of Administration
Exhibits47: Data Table on Comparison by Route of Administration
Exhibits48: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Route of Administration ($ million)
Exhibits57: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Amgen Inc. - Overview
Exhibits108: Amgen Inc. - Product / Service
Exhibits109: Amgen Inc. - Key offerings
Exhibits110: AstraZeneca Plc - Overview
Exhibits111: AstraZeneca Plc - Product / Service
Exhibits112: AstraZeneca Plc - Key news
Exhibits113: AstraZeneca Plc - Key offerings
Exhibits114: Aurobindo Pharma Ltd. - Overview
Exhibits115: Aurobindo Pharma Ltd. - Product / Service
Exhibits116: Aurobindo Pharma Ltd. - Key offerings
Exhibits117: Bausch Health Companies Inc. - Overview
Exhibits118: Bausch Health Companies Inc. - Business segments
Exhibits119: Bausch Health Companies Inc. - Key news
Exhibits120: Bausch Health Companies Inc. - Key offerings
Exhibits121: Bausch Health Companies Inc. - Segment focus
Exhibits122: Bayer AG - Overview
Exhibits123: Bayer AG - Business segments
Exhibits124: Bayer AG - Key news
Exhibits125: Bayer AG - Key offerings
Exhibits126: Bayer AG - Segment focus
Exhibits127: Dr Reddys Laboratories Ltd. - Overview
Exhibits128: Dr Reddys Laboratories Ltd. - Business segments
Exhibits129: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits130: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits131: Eisai Co. Ltd. - Overview
Exhibits132: Eisai Co. Ltd. - Business segments
Exhibits133: Eisai Co. Ltd. - Key offerings
Exhibits134: Eisai Co. Ltd. - Segment focus
Exhibits135: Eli Lilly and Co. - Overview
Exhibits136: Eli Lilly and Co. - Product / Service
Exhibits137: Eli Lilly and Co. - Key news
Exhibits138: Eli Lilly and Co. - Key offerings
Exhibits139: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits140: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits141: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits142: Pfizer Inc. - Overview
Exhibits143: Pfizer Inc. - Product / Service
Exhibits144: Pfizer Inc. - Key news
Exhibits145: Pfizer Inc. - Key offerings
Exhibits146: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits147: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits148: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits149: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits150: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits151: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits152: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits153: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits154: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits155: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits156: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits157: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits158: The Procter and Gamble Co. - Overview
Exhibits159: The Procter and Gamble Co. - Business segments
Exhibits160: The Procter and Gamble Co. - Key news
Exhibits161: The Procter and Gamble Co. - Key offerings
Exhibits162: The Procter and Gamble Co. - Segment focus
Exhibits163: Zydus Lifesciences Ltd. - Overview
Exhibits164: Zydus Lifesciences Ltd. - Business segments
Exhibits165: Zydus Lifesciences Ltd. - Key offerings
Exhibits166: Zydus Lifesciences Ltd. - Segment focus
Exhibits167: Inclusions checklist
Exhibits168: Exclusions checklist
Exhibits169: Currency conversion rates for US$
Exhibits170: Research methodology
Exhibits171: Validation techniques employed for market sizing
Exhibits172: Information sources
Exhibits173: List of abbreviations